Po‐Ming Chen

1.0k total citations
45 papers, 709 citations indexed

About

Po‐Ming Chen is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Po‐Ming Chen has authored 45 papers receiving a total of 709 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 14 papers in Cancer Research and 12 papers in Oncology. Recurrent topics in Po‐Ming Chen's work include RNA modifications and cancer (9 papers), MicroRNA in disease regulation (6 papers) and Cancer Cells and Metastasis (5 papers). Po‐Ming Chen is often cited by papers focused on RNA modifications and cancer (9 papers), MicroRNA in disease regulation (6 papers) and Cancer Cells and Metastasis (5 papers). Po‐Ming Chen collaborates with scholars based in Taiwan, China and Oman. Po‐Ming Chen's co-authors include Pei‐Yi Chu, Wei-Chieh Huang, Shiao-Lin Tung, Yao‐Li Chen, Ping‐Yi Lin, Lu‐Hai Wang, Sheng‐Chieh Lin, Yayu Yang, Shuang‐En Chuang and Te‐Hsuan Jang and has published in prestigious journals such as Advanced Functional Materials, Oncogene and Scientific Reports.

In The Last Decade

Po‐Ming Chen

43 papers receiving 707 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Po‐Ming Chen Taiwan 15 347 211 206 84 76 45 709
Man Liu China 14 375 1.1× 287 1.4× 143 0.7× 181 2.2× 89 1.2× 43 825
Jo Ann Dumin United States 8 231 0.7× 191 0.9× 366 1.8× 44 0.5× 28 0.4× 12 847
Jonathan C. M. Clark Australia 14 488 1.4× 217 1.0× 300 1.5× 39 0.5× 294 3.9× 18 957
Wiktor Paskal Poland 14 229 0.7× 156 0.7× 168 0.8× 81 1.0× 38 0.5× 36 638
Sepideh Alavi-Moghadam Iran 15 351 1.0× 68 0.3× 79 0.4× 44 0.5× 33 0.4× 44 675
Yanru Xue China 11 254 0.7× 74 0.4× 109 0.5× 37 0.4× 116 1.5× 37 644
Yueqi Wang China 16 345 1.0× 205 1.0× 185 0.9× 132 1.6× 146 1.9× 61 910
Silvia Monteagudo Belgium 17 444 1.3× 96 0.5× 123 0.6× 46 0.5× 23 0.3× 33 874
Zehao Wang China 11 328 0.9× 60 0.3× 212 1.0× 56 0.7× 80 1.1× 28 525
Fuqiang Yin China 21 539 1.6× 150 0.7× 324 1.6× 54 0.6× 125 1.6× 49 968

Countries citing papers authored by Po‐Ming Chen

Since Specialization
Citations

This map shows the geographic impact of Po‐Ming Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Po‐Ming Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Po‐Ming Chen more than expected).

Fields of papers citing papers by Po‐Ming Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Po‐Ming Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Po‐Ming Chen. The network helps show where Po‐Ming Chen may publish in the future.

Co-authorship network of co-authors of Po‐Ming Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Po‐Ming Chen. A scholar is included among the top collaborators of Po‐Ming Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Po‐Ming Chen. Po‐Ming Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Lin, et al.. (2025). MCP-1 Reduction by L-SIGN Expression in Dengue Virus-Infected Liver Endothelial Cells. Viruses. 17(3). 344–344. 1 indexed citations
2.
Chen, Yu‐Chia, et al.. (2025). Silymarin Ameliorates Tacrolimus-induced Inflammation in Human Umbilical Vein Endothelial Cells. In Vivo. 39(5). 2617–2628.
3.
Cheng, Chun‐Wen, Yu‐Fan Liu, Wen‐Ling Liao, et al.. (2024). miR-622 Increases miR-30a Expression through Inhibition of Hypoxia-Inducible Factor 1α to Improve Metastasis and Chemoresistance in Human Invasive Breast Cancer Cells. Cancers. 16(3). 657–657. 3 indexed citations
4.
Chen, Yu‐Chia, Hsin‐Hung Chen, & Po‐Ming Chen. (2024). Catalase expression is an independent prognostic marker in liver hepatocellular carcinoma. ONCOLOGIE. 26(1). 79–90. 8 indexed citations
5.
Chen, Po‐Ming, et al.. (2023). SGK1 Target Genes Involved in Heart and Blood Vessel Functions in PC12 Cells. Cells. 12(12). 1641–1641. 2 indexed citations
6.
Chen, Po‐Ming, et al.. (2023). Actin-like Protein 6A Expression Correlates with Cancer Stem Cell-like Features and Poor Prognosis in Ovarian Cancer. International Journal of Molecular Sciences. 24(3). 2016–2016. 5 indexed citations
7.
Chen, Po‐Ming, et al.. (2023). Catalase Expression Is an Independent Prognostic Marker in Lung Adenocarcinoma. Anticancer Research. 44(1). 287–300.
8.
Chen, Rong‐Fu, et al.. (2023). Association of metallothionein 2A rs10636 with low mean corpuscular volume (MCV), low mean corpuscular haemoglobin (MCH) in healthy Taiwanese. Scientific Reports. 13(1). 1292–1292. 1 indexed citations
9.
Jang, Te‐Hsuan, Wei-Chieh Huang, Shiao-Lin Tung, et al.. (2022). MicroRNA-485-5p targets keratin 17 to regulate oral cancer stemness and chemoresistance via the integrin/FAK/Src/ERK/β-catenin pathway. Journal of Biomedical Science. 29(1). 42–42. 69 indexed citations
10.
Chen, Po‐Ming, et al.. (2020). Bioinspired Engineering of a Bacterium‐Like Metal–Organic Framework for Cancer Immunotherapy. Advanced Functional Materials. 30(42). 30 indexed citations
11.
Chen, Ming‐Jenn, Ching‐Ju Shen, Lee Wang, et al.. (2020). Association of hOGG1‐Cys variants with occurrence of p53 and EGFR deletion mutations in non‐small cell lung cancer. Thoracic Cancer. 12(4). 534–538. 3 indexed citations
12.
Chen, Ming‐Jenn, Po‐Ming Chen, Lee Wang, et al.. (2020). Cisplatin sensitivity mediated by NKX2-1 in lung adenocarcinoma is dependent on p53 mutational status via modulating TNFSF10 expression.. PubMed. 10(4). 1229–1237. 3 indexed citations
13.
Hou, Ming‐Feng, Po‐Ming Chen, & Pei‐Yi Chu. (2018). LGR5 overexpression confers poor relapse-free survival in breast cancer patients. BMC Cancer. 18(1). 219–219. 36 indexed citations
14.
Huang, Wei-Chieh, Shiao-Lin Tung, Yao‐Li Chen, Po‐Ming Chen, & Pei‐Yi Chu. (2018). IFI44L is a novel tumor suppressor in human hepatocellular carcinoma affecting cancer stemness, metastasis, and drug resistance via regulating met/Src signaling pathway. BMC Cancer. 18(1). 609–609. 46 indexed citations
15.
Dhondge, Attrimuni P., et al.. (2018). Angular-Shaped Naphthalene Bis(1,5-diamide-2,6-diylidene)malononitrile for High-Performance, Air-Stable N-Type Organic Field-Effect Transistors. Organic Letters. 20(9). 2538–2542. 17 indexed citations
16.
Chen, Po‐Ming, Pei‐Yi Chu, Shiao-Lin Tung, et al.. (2017). Overexpression of phosphoprotein phosphatase 2A predicts worse prognosis in patients with breast cancer: a 15-year follow-up. Human Pathology. 66. 93–100. 8 indexed citations
17.
Chen, Yao‐Li, Ping‐Yi Lin, Yingzi Ming, et al.. (2017). The effects of the location of cancer stem cell marker CD133 on the prognosis of hepatocellular carcinoma patients. BMC Cancer. 17(1). 474–474. 41 indexed citations
18.
Chen, Po‐Ming, et al.. (2016). Beneficial effects of bipolar hemiarthroplasty replacement and fosamax in the retrospective cohort study of refracture and mortality of hip fractured patients.. PubMed. 29(3 Suppl). 1071–5. 1 indexed citations
19.
Li, Chia-Ying, Pei‐Ming Huang, Pei‐Yi Chu, et al.. (2016). Predictors of Survival in Esophageal Squamous Cell Carcinoma with Pathologic Major Response after Neoadjuvant Chemoradiation Therapy and Surgery: The Impact of Chemotherapy Protocols. BioMed Research International. 2016. 1–8. 9 indexed citations
20.
Li, Chunyi, Chih‐Cheng Chen, Jie‐Yu You, et al.. (2007). Combined Treatment with Splenectomy and Cladribine in Hairy Cell Leukemia in Taiwan: A Clinicopathologic Study of 5 Cases. Journal of the Chinese Medical Association. 70(12). 551–555. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Man Liu Breakdown of academic impact, for papers by Jo Ann Dumin Breakdown of academic impact, for papers by Jonathan C. M. Clark Breakdown of academic impact, for papers by Wiktor Paskal Breakdown of academic impact, for papers by Sepideh Alavi-Moghadam Breakdown of academic impact, for papers by Yanru Xue Breakdown of academic impact, for papers by Yueqi Wang Breakdown of academic impact, for papers by Silvia Monteagudo Breakdown of academic impact, for papers by Zehao Wang Breakdown of academic impact, for papers by Fuqiang Yin
Rankless by CCL
2026